Found 4 Enz. Inhib. hit(s) with Target = 'MAP kinase-interacting serine/threonine-protein kinase 2' and Ligand = 'BDBM50562615'
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
Ryvu Therapeutics
Curated by ChEMBL
Ryvu Therapeutics
Curated by ChEMBL
Affinity DataKi: 5.5nMAssay Description:ATP-competitive inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system ...More data for this Ligand-Target Pair
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
Ryvu Therapeutics
Curated by ChEMBL
Ryvu Therapeutics
Curated by ChEMBL
Affinity DataIC50: 5.40nMAssay Description:Inhibition of recombinant MNK2 (unknown origin) in presence of ATP by ADP--Glo kinase assayMore data for this Ligand-Target Pair
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
Ryvu Therapeutics
Curated by ChEMBL
Ryvu Therapeutics
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR...More data for this Ligand-Target Pair
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
Ryvu Therapeutics
Curated by ChEMBL
Ryvu Therapeutics
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of Mnk2 (unknown origin)More data for this Ligand-Target Pair